89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
about
First-in-human HER2-targeted imaging using 89Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer.Radioiodinated Small Molecule Tyrosine Kinase Inhibitor for HER2 Selective SPECT Imaging.Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
P2860
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@en
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@nl
type
label
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@en
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@nl
prefLabel
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@en
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@nl
P2093
P2860
P1476
89Zr-Trastuzumab PET/CT for De ...... egative Primary Breast Cancer.
@en
P2093
David M Hyman
Gary A Ulaner
Jason S Lewis
Jorge A Carrasquillo
Serge K Lyashchenko
P2860
P304
P356
10.1097/RLU.0000000000001820
P577
2017-09-01T00:00:00Z